Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
Titel:
Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study
Auteur:
Dunleavy, Kieron Fanale, Michelle A Abramson, Jeremy S Noy, Ariela Caimi, Paolo Fabrizio Pittaluga, Stefania Parekh, Samir Lacasce, Ann Hayslip, John W Jagadeesh, Deepa Nagpal, Sunil Lechowicz, Mary Jo Gaur, Rakesh Lucas, Andrea Melani, Christopher Roschewski, Mark Steinberg, Seth M Jaffe, Elaine S Kahl, Brad Friedberg, Jonathan W Little, Richard F Bartlett, Nancy L Wilson, Wyndham H